Antibody or Antibody Fragments: Implications for Molecular Imaging and Targeted Therapy of Solid Tumors

Frontiers in Immunology
Katerina T XenakiPaul M P van Bergen En Henegouwen

Abstract

The use of antibody-based therapeutics has proven very promising for clinical applications in cancer patients, with multiple examples of antibodies and antibody-drug conjugates successfully applied for the treatment of solid tumors and lymphomas. Given reported recurrence rates, improvements are clearly still necessary. A major factor limiting the efficacy of antibody-targeted cancer therapies may be the incomplete penetration of the antibody or antibody-drug conjugate into the tumor. Incomplete tumor penetration also affects the outcome of molecular imaging, when using such targeting agents. From the injection site until they arrive inside the tumor, targeting molecules are faced with several barriers that impact intratumoral distribution. The primary means of antibody transport inside tumors is based on diffusion. The diffusive penetration inside the tumor is influenced by both antibody properties, such as size and binding affinity, as well as tumor properties, such as microenvironment, vascularization, and targeted antigen availability. Engineering smaller antibody fragments has shown to improve the rate of tumor uptake and intratumoral distribution. However, it is often accompanied by more rapid clearance from the body and ...Continue Reading

References

May 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·S K HobbsR K Jain
Jul 3, 1999·Physiological Reviews·C C Michel, F E Curry
Aug 3, 1999·Nature Biotechnology·A P ChapmanD J King
Mar 29, 2001·Proceedings of the National Academy of Sciences of the United States of America·A PluenR K Jain
Aug 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·R K Jain
Aug 31, 2002·Biophysical Journal·Saroja RamanujanRakesh K Jain
Oct 29, 2004·Nature Reviews. Cancer·Carl-Henrik HeldinArne Ostman
Sep 10, 2005·Nature Biotechnology·Philipp Holliger, Peter J Hudson
Jul 25, 2006·Nature Reviews. Cancer·Andrew I Minchinton, Ian F Tannock
Jan 11, 2007·Cancer Research·Mark S DennisRalph Schwall
Feb 21, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maneesh JainSurinder K Batra
Aug 19, 2007·Nature Reviews. Immunology·Derry C Roopenian, Shreeram Akilesh
Sep 25, 2007·Nature Biotechnology·Hak Soo ChoiJohn V Frangioni
Jan 9, 2008·Trends in Pharmacological Sciences·Greg M ThurberK Dane Wittrup
May 13, 2008·Nature Reviews. Cancer·Klaus Strebhardt, Axel Ullrich
Jun 11, 2008·Advanced Drug Delivery Reviews·Greg M ThurberK Dane Wittrup
Apr 9, 2009·Nature Biotechnology·Aaron L Nelson, Janice M Reichert
Oct 15, 2009·Molecular Cancer Therapeutics·Michael M Schmidt, K Dane Wittrup
Sep 8, 2010·Protein Engineering, Design & Selection : PEDS·Jonas HoppRoland E Kontermann
Sep 15, 2010·Nature Reviews. Clinical Oncology·Rakesh K Jain, Triantafyllos Stylianopoulos
Apr 27, 2011·International Journal of Cancer. Journal International Du Cancer·Rob C RooversPaul M P van Bergen en Henegouwen
Jun 2, 2011·Nature Reviews. Drug Discovery·Peter Carmeliet, Rakesh K Jain
Mar 23, 2012·Nature Reviews. Cancer·Andrew M ScottLloyd J Old
Dec 18, 2012·Nano Today·Joseph W Nichols, You Han Bae
Jun 20, 2013·European Journal of Nuclear Medicine and Molecular Imaging·Marta KijankaPaul M P van Bergen En Henegouwen
Aug 15, 2013·Journal of Cell Science·Raimond HeukersPaul M P van Bergen En Henegouwen
Sep 10, 2014·Critical Reviews in Oncology/hematology·Roeland LamerisHans J van der Vliet
Nov 27, 2014·Expert Opinion on Drug Delivery·Hideaki NakamuraHiroshi Maeda
Jan 7, 2015·Annual Review of Pharmacology and Toxicology·Andreas Plückthun
Feb 1, 2015·Molecular Immunology·Christoph SpiessPaul J Carter
Aug 19, 2015·Nanomedicine : Nanotechnology, Biology, and Medicine·Triantafyllos Stylianopoulos, Rakesh K Jain
Mar 12, 2016·Expert Opinion on Biological Therapy·Roland E Kontermann
Mar 19, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Pieter B A A van DrielSabrina Oliveira
Jul 3, 2016·Advanced Drug Delivery Reviews·Yin WangHonggang Cui

❮ Previous
Next ❯

Citations

Oct 20, 2018·International Journal of Cancer. Journal International Du Cancer·Jing ChenBing Wang
Aug 17, 2019·Chemistry : a European Journal·Alberto Dal CorsoCesare Gennari
Dec 11, 2019·Antibodies·Mark L ChiuGary L Gilliland
Mar 16, 2018·Oncotarget·Meike HuttRoland E Kontermann
Jun 10, 2020·Fungal biology and biotechnology·Hung Hiep HuynhJun-Ichi Maruyama
Sep 15, 2020·Macromolecular Bioscience·Sebastian G HuayamaresCory J Berkland
Oct 1, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·S TahmasebiA Esmaeilzadeh
Mar 31, 2018·Antibodies·Mahendra P DeonarainAshleigh C Stewart
May 20, 2020·Biomolecules·Dobeen Hwang, Christoph Rader
Apr 16, 2019·Frontiers in Oncology·Nicholas G MinutoloDaniel J Powell
Oct 24, 2019·Journal for Immunotherapy of Cancer·Hao LiuKun Cheng
Feb 23, 2020·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Lotte K KristensenAndreas Kjaer
Jun 13, 2020·Frontiers in Pharmacology·Franziska HartungLuis A Pardo
Aug 23, 2020·International Journal of Molecular Sciences·Alberto JuanCarlos Alonso-Moreno
Mar 13, 2019·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Irati Beltrán HernándezSabrina Oliveira
Dec 13, 2019·Scientific Reports·Fokko J HuizingSandra Heskamp
Aug 29, 2020·Pharmaceutics·Alberto JuanCarlos Alonso-Moreno
May 30, 2019·Frontiers in Pharmacology·Pieterjan Debie, Sophie Hernot
Jan 17, 2020·Pharmaceutics·Marco CavacoVera Neves
Mar 1, 2019·Nature Reviews. Rheumatology·Anja S Schmid, Dario Neri
Feb 9, 2020·Scientific Reports·Nicola MitwasiMichael Bachmann
Dec 9, 2020·Chemical Society Reviews·Stephen J WalshDavid R Spring
Oct 31, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Arutselvan NatarajanSanjiv S Gambhir
Nov 22, 2020·Life Sciences·Sepideh GhaniBahram Kazemi
Jan 19, 2021·Nuclear Medicine and Biology·Dmitry FilosofovValery Radchenko
Feb 16, 2021·Regulatory Toxicology and Pharmacology : RTP·Francesca Pretto, Rex E FitzGerald
Jan 22, 2021·Bioconjugate Chemistry·Camille M Le GallMartijn Verdoes
Jan 21, 2021·Biomedicines·Kyusang HwangSukmook Lee
Mar 18, 2021·Therapeutic Delivery·Ole A Mandrup, Kenneth A Howard
Jul 12, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Eva RandárováTomáš Etrych
May 1, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Virginia LiberiniDésirée Deandreis
Dec 12, 2020·Pharmacology & Therapeutics·Alizée BouleauCharles Truillet
Jul 3, 2021·Cancers·Yuchen JinWeijun Wei
Jun 18, 2021·Nano-micro Letters·Shruti Rawal, Mayur Patel
Jul 3, 2021·International Journal of Molecular Sciences·Chris ViSarah Shigdar
Jul 11, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Imke Rudnik-Jansen, Kenneth A Howard

❮ Previous
Next ❯

Methods Mentioned

BETA
xenografts

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Greg M ThurberK Dane Wittrup
Nanomedicine
Marta KijankaPaul M P van Bergen En Henegouwen
International Journal of Immunopharmacology
J N Weinstein, W van Osdol
Trends in Biotechnology
Angel M CuestaLuis Alvarez-Vallina
© 2022 Meta ULC. All rights reserved